← Leaderboards
Timothy I Richardson
Indiana University Indianapolis
$5,312,586
Attributed
$7,482,573
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$19,140,951 · 6
By mechanism
U54$16,131,439 · 4
U01$2,217,438 · 1
R01$792,074 · 1
Top collaborators
- Bruce T Lamb3 shared
- Adrian Lynn Oblak2 shared
- Alan D. Palkowitz2 shared
- Scott G Canfield1 shared
- Jeffrey Dage1 shared
- Feng Guo1 shared
- Kun Huang1 shared
- Andrew D Mesecar1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Reuben Kapur$21,257,649
- Alon Harris$1,562,726
- Jason Stephen Meyer$10,504,585
- Li Shen$13,717,828
- Lesley Nicole Weaver$2,214,138
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposBiologicalS DiseaseDesignPharmacodynamicsDrug DiscoveryAntibodiesIn VivoPharmacodynamic BiomarkerS Disease ModelAmyloid Beta-ProteinSafetyCellsDrug KineticsPropertyPathway InteractionsPharmaceutical PreparationsMicrogliaNeuroinflammationAnimal ModelMolecularDoseIndianaNerve Degeneration
Grant awards (6)
IUSM TREAT-AD Center$8,323,362
U54 · FY2025 · AG
Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)$3,335,016
U54 · FY2025 · AG
Medicinal Chemistry and Chemical Biology Core (MCCB)$3,206,036
U54 · FY2025 · AG · contact PI
Optimization of SHIP1 Inhibitors for the Treatment of Alzheimer's Disease$2,217,438
U01 · FY2025 · AG · contact PI
Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)$1,267,025
U54 · FY2025 · AG · contact PI
siRNA-mediated Knockdown of INPP5D to Modulate Microglia Activity for the Treatment of Alzheimer's Disease$792,074
R01 · FY2025 · AG · contact PI